Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2008 08:19 ET | Source: Ceragenix Pharmaceuticals

Ceragenix to Present Urinary Catheter Data at European Conference

DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it will be...
April 07, 2008 08:27 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Receives $1.5 Million Milestone Payment

DENVER, Apr 07, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:GXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that...
March 25, 2008 08:09 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Enters into Agreement to License CSA-54 and other Ceragenin Compounds To Biopharmaceutical Company for HIV and STD Applications

DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it has entered...
March 13, 2008 17:47 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Completes Patient Visit Phase of Clinical Trial Study to Compare Efficacy of EpiCeram(R) to Elidel(R)

DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) (the "Company"), a biopharmaceutical and medical device company focused on infectious disease and dermatology, today announced that it had...
January 29, 2008 09:10 ET | Source: Ceragenix Pharmaceuticals

Dr. Michael Niederman Joins Ceragenix Scientific Advisory Board

DENVER, Jan 29, 2008 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that Michael S. Niederman MD, FACP,...
December 20, 2007 08:14 ET | Source: Ceragenix Pharmaceuticals

Ceragenin(TM) Compound Demonstrates Potent Activity Against Multidrug Resistant Bacterial Strains of Pseudomonas

DENVER--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that researchers at the Eugene Appelbaum College of...
November 19, 2007 09:27 ET | Source: Ceragenix Pharmaceuticals

Ceragenix and Dr. Reddy's Enter Into Distribution and Supply Agreement for EpiCeram(r)

DENVER--Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology today announced that it has entered into an exclusive distribution and...
October 31, 2007 13:10 ET | Source: Ceragenix Pharmaceuticals

Ceragenix Pharmaceuticals to Present at The Rodman and Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th

DENVER -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that Steven Porter, its Chairman and Chief Executive...
October 22, 2007 08:37 ET | Source: Ceragenix Pharmaceuticals

Results of Pre-Clinical Investigation of Ceragenix's Developmental Antibiotic to Prevent Sepsis Presented at International Scientific Meeting

DENVER, Oct 22, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that researchers at the Johns Hopkins...
September 18, 2007 08:30 ET | Source: Ceragenix Pharmaceuticals

Results of Pre-Clinical Investigations of Ceragenix's Developmental Antibiotic to Be Presented at International Scientific Meeting on Infectious Diseases

DENVER, Sep 18, 2007 -- Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused on infectious disease and dermatology, today announced that five poster presentations on the...